233 related articles for article (PubMed ID: 24956436)
1. Biomarkers for virus-induced hepatocellular carcinoma (HCC).
Mathew S; Ali A; Abdel-Hafiz H; Fatima K; Suhail M; Archunan G; Begum N; Jahangir S; Ilyas M; Chaudhary AG; Al Qahtani M; Mohamad Bazarah S; Qadri I
Infect Genet Evol; 2014 Aug; 26():327-39. PubMed ID: 24956436
[TBL] [Abstract][Full Text] [Related]
2. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic activity of hepatitis B and C viruses.
Vrancken K; Paeshuyse J; Liekens S
Antivir Chem Chemother; 2012 Jan; 22(4):159-70. PubMed ID: 22182803
[TBL] [Abstract][Full Text] [Related]
4. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus, alcoholic cirrhosis, and hepatocellular carcinoma.
Goeser T; Müller HM; Solbach C; Toex U; Kommerell B; Theilmann L
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):311-5. PubMed ID: 8061579
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
Brunetto MR; Oliveri F; Colombatto P; Bonino F
Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
[TBL] [Abstract][Full Text] [Related]
7. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.
Song PP; Xia JF; Inagaki Y; Hasegawa K; Sakamoto Y; Kokudo N; Tang W
World J Gastroenterol; 2016 Jan; 22(1):262-74. PubMed ID: 26755875
[TBL] [Abstract][Full Text] [Related]
8. Roles of long noncoding RNAs in hepatocellular carcinoma.
Shi L; Peng F; Tao Y; Fan X; Li N
Virus Res; 2016 Sep; 223():131-9. PubMed ID: 27374059
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
10. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
11. [Co-infection of HBV with HCV and a possible role of HBV DNA in hepatocarcinogenesis].
Koike K
Nihon Rinsho; 1999 Jan; 57(1):213-9. PubMed ID: 10036965
[TBL] [Abstract][Full Text] [Related]
12. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan.
Lu SN; Su WW; Yang SS; Chang TT; Cheng KS; Wu JC; Lin HH; Wu SS; Lee CM; Changchien CS; Chen CJ; Sheu JC; Chen DS; Chen CH
Int J Cancer; 2006 Oct; 119(8):1946-52. PubMed ID: 16708389
[TBL] [Abstract][Full Text] [Related]
13. Expression pattern analysis of hepatocellular carcinoma tumor markers in viral hepatitis B and C patients undergoing liver transplantation and resection.
Ha TY; Hwang S; Kim KH; Lee YJ; Ahn CS; Moon DB; Song GW; Park KM; Kim N; Lee SG
Transplant Proc; 2014 Apr; 46(3):888-93. PubMed ID: 24767373
[TBL] [Abstract][Full Text] [Related]
14. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues.
Edamoto Y; Tani M; Kurata T; Abe K
Cancer; 1996 May; 77(9):1787-91. PubMed ID: 8646675
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
17. Etiological and molecular profile of hepatocellular cancer from India.
Asim M; Sarma MP; Kar P
Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
[TBL] [Abstract][Full Text] [Related]
18. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
El-Aneed A; Banoub J
Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis viruses as aetiological agents of hepatocellular carcinoma.
Alberti A; Pontisso P
Ital J Gastroenterol; 1991; 23(7):452-6. PubMed ID: 1660332
[TBL] [Abstract][Full Text] [Related]
20. Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma.
Van Hees S; Michielsen P; Vanwolleghem T
World J Gastroenterol; 2016 Oct; 22(37):8271-8282. PubMed ID: 27729734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
